“There are six major types of hepatitis C – genotypes 1−6. In Australia, about half of cases are caused by genotype 1, a third by genotype 3 and 5% by genotype 2. Until recently, standard treatment for chronic hepatitis C infection was with peginterferon and ribavirin . Protease inhibitors boceprevir and telaprevir were approved in 2012. Adding either of these to peginterferon and ribavirin seems to improve the response rates in people with genotype 1 disease. Sofosbuvir is another antiviral drug that can be added to combination treatment for chronic hepatitis C. “It is a direct-acting nucleotide polymerase inhibitor. You can read more about this drug in the enclosed information produced by The Australian Prescriber!